Table 2.
Diabetes history, biochemical parameters and blood pressure among study participants
| No | Percent | ||
|---|---|---|---|
| Duration of DM | Recently diagnosed (> 1 months) |
24 | 12.5 |
| 1 month to 5 years | 102 | 53.1 | |
| 5 years to 10 years | 30 | 15.6 | |
| More than 10 years | 36 | 18.8 | |
| Current antidiabetes medication | Biguinades | 68 | 35.4 |
| Insulin | 14 | 7.3 | |
| Sulphonylurea | 10 | 5.2 | |
| Biguinades + Sulphonylurea | 50 | 26 | |
| Biguinades + Insulin | 20 | 10.4 | |
| Biguinades + Insulin + Sulphonylurea | 12 | 6.2 | |
| Biguinades + Acarbose inhibitor | 4 | 2.1 | |
| Other combinations of above-mentioned drugs | 14 | 7.3 | |
| Biochemical parameters | RBS (mg/dL); mean (SD) | 279.16 (126.70) | |
| FBS (mg/dL); mean (SD) | 160.66 (76.38) | ||
| PMBS (mg/dL); mean (SD) | 243.73 (96.32) | ||
| T-Cholesterol (mg/dL); mean (SD) | 174.55 (48.63) | ||
| HDL, (mg/dL); mean (SD) | 38.88 (4.94) | ||
| LDL, (mg/dL); mean (SD) | 102.15 (35.04) | ||
| TG, (mg/dL); mean (SD) | 163.65 (87.96) | ||
| Blood pressure (mmHg) JNC 8 criteria | Normal | 52 | 27.1 |
| Prehypertension | 88 | 45.8 | |
| Hypertension, stage 1 | 42 | 21.9 | |
| Hypertension, stage 2 | 10 | 5.2 | |